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ABSTRACT
SYSTEMS MODELING OF CALCIUM HOMEOSTASIS AND MOBILIZATION IN
PLATELETS MEDIATED BY IP3 AND STORE-OPERATED CALCIUM ENTRY
Andrew T. Dolan
Scott L. Diamond

Platelet aggregation is one of the body’s first responses to vascular damage to prevent
blood loss; upon injury to the endothelium platelets react to the exposed extracellular
matrix and undergo a host of intracellular biochemical changes enabling them to activate
and form a “plug” at the site of injury. Internally, platelets respond to their environment
by exhibiting a sharp rise in cytosolic calcium that triggers a series of chemical and
morphological changes which are critical to platelet activation and subsequent clot
propagation. This thesis develops a mechanistic, computational model of platelet calcium
regulation using coupled sets of ordinary differential equations. This thesis extends
previous work modeling calcium release mediated by inositol 1,4,5-trisphosphate (IP3) to
engineer what is the first, to date, complete model of store-operated calcium entry
(SOCE) integrated into a systems model for calcium signaling. SOCE is a ubiquitous
extracellular calcium entry pathway which is activated by calcium store depletion, is seen
in many cells types and is yet to be fully understood. Our model for SOCE regulation
consists of diffusion-limited dimerization of the calcium sensor STIM1, followed by fast,
cytosolic calcium-dependent association of STIM1 dimers with Orai1 channels in the
plasma membrane resulting in graded store-operated channel activation. Appropriate
model resting states were characterized using a dense Monte Carlo technique on an initial
condition sampling space constrained by available data on species concentrations and
iv

protein copy numbers. From this set of resting configurations, following application of
physiologic IP3 stimuli, we selected for resting states exhibiting calcium dynamics that
are in agreement with experimental data. We also selected for states presenting
significant SOCE current based on differences in cytosolic calcium between simulations
run with and without extracellular calcium. Low resting levels of IP3 are required for
system robustness and for simultaneous appropriate dynamic response to physiologic
agonists. Platelets require a resting electrical potential across the membrane surrounding
the calcium stores of greater than -70 mV in order to exhibit significant agonist-induced
calcium release.
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Chapter 1
Introduction
Cells interact with their environment by sensing external chemical signals through
binding events at receptors on their surface. External signals are transmitted internally by
a successive relay of chemical reactions occurring within the cell’s cytoplasm and
organelles. These chemical changes ultimately manifest in a change in the cell’s
phenotype or behavior. Some individual biochemical reactions in cells are relatively
simple. Consider the hydrolysis of sucrose to glucose and fructose catalyzed by invertase.
In this case the reaction can be fully characterized by a Michaelis-Menten relationship
and a few fixed parameters. However there are many such reactions occurring
simultaneously within cells and even just a few nonlinear interactions can produce
complex and completely counterintuitive behavior. An example is the “chemical clock”
Belousov-Zhabotinsky reaction where just a few reactants will spontaneously form
numerous pulsing, spiraling waves of oscillating color until the reactants are consumed
[1]. Another would be the complex, unique fractal structures of snowflakes forming from
crystallizing water droplets. These are examples of the phenomenon of emergence, or
1

how complex behaviors arise from relatively simple interactions. In biology, nonlinear
chemical or physical couplings among biomolecules, inorganic ions and other
compounds allow cells to function as biochemical systems which are far greater than the
sum of their parts.
Some examples of emergent behavior in biology include


Cell differentiation during development. A central question in developmental
biology is how groups of precursor cells can selectively differentiate to form
organs. Using the Drosophila fruit fly as a model, many seminal studies revealed
such patterned development arises from concentration gradients of morphogenic
compounds. These gradients are the consequence of directed transport through the
tissue, or nondirectional secretion from cells. Through binding and activating cell
surface receptors, the morphogens themselves can affect the rate of secretion,
creating a feedback loop reliant on intracellular kinetics and processes [2].



Spread of infectious disease. The spread of pathogens through a population is
strongly influenced by the rate of propagation of the disease between organisms.
These rates are affected by population factors such as environment or
demographics and individual factors like behavior and health. At the molecular
biology level, acquired immunity or resistance, and genetic immune disorders also
affect transmission. With the increasing amount of demographic data available,
agent based modeling finds utility in incorporating data on average individual’s
daily activities, social interactions, and travels to develop models that allow
agencies such as the CDC to anticipate risk of contagion of new pathogens.
2



Thrombus formation in damaged blood vessels. Thrombus formation involves
chemical reactions in the flowing blood occurring in response to exposed
compounds in the damaged vessel wall to generate thrombin, and activation of
rolling or captured platelets by thrombin and collagen on the endothelium via
outside-in cell signaling. Activated platelets can aggregate at the wound site using
fibrin, which is generated by thrombin, as a scaffold. Platelets also release
agonists to cause autocrine and paracrine signaling and can serve as a substrate
for thrombin generation. These interactions make thrombosis a truly multiscale
process resulting from complex interactions at the molecular to the cellular level.
Molecular biology is often reductionist in nature. The goal of systems biology is

to integrate individual complex cell signaling mechanisms to predict emergent behavior
at the cellular, tissue, or organismal scale1. As both the quantity of biological data and
available computing power increase at exponential rates, computational models become a
natural tool for this purpose. The most common computational approach taken is to use
networks of ordinary differential equations to model the interactions of every reactant in
a detailed manner; techniques such as molecular dynamics can be useful in providing
information about individual components in these networks [3].
This thesis focuses on the application of these holistic modeling approaches to
intracellular signaling in one biological system in particular - human platelets. These cells
play important roles in cessation of blood flow and wound healing following injury as
well as in cardiovascular diseases. The major objective of this work is to model how the
1

Our discussion is limited to how metabolic or genomic reactions integrate at the cellular level however
this concept can readily be extended to how cells integrate to form tissues and organs, which in turn
interact to form entire organisms.
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platelet responds to chemical agonists generated during blood clot formation. Chapter 2
shows how a previously developed bottom-up model of G-protein coupled receptor
mediated calcium regulation was extended to include mechanisms for calcium influx
from the extracellular space. In Chapter 3, a dense Monte Carlo sampling is applied to a
physiologically constrained initial condition and parameter search space to reveal how
the programmed topology (i.e. the reaction network) affects the model’s preferred resting
states. These resting configurations are then characterized based on their cytosolic
calcium responses to a transient stimulatory input. The remainder of this chapter will
provide background on the biology and clinical relevance of platelets (Section 1.1), a
brief introduction to the systems biology modeling paradigm (Section 1.2), an overview
of some previous platelet calcium signaling modeling work (Section 1.3) and end with a
discussion and overview of store-operated calcium entry (Section 1.4), the extracellular
calcium entry mechanism that we seek to model.

1.1 Platelets: Biology and Significance
Platelets are critical mediators of hemostasis, the process of stopping blood loss
following injury to a blood vessel. The blood is a complex fluid environment consisting
of red blood cells, white blood cells, and platelets; the noncellular portion of blood,
plasma, is a complex chemical cocktail of ions and proteins. Platelets must be able to
precisely respond to chemical or physical signals and changes in this environment to
initiate thrombosis, the process of blood clot formation, while being robust to small
stochastic changes so as not to activate at inappropriate times (e.g. in the absence of an
actual injury). Dysregulation or diseases such as atherosclerosis can result in pathological
4

thrombus formation and embolism, which is the process where a blood clot breaks loose
from the blood vessel wall and travels through the bloodstream. When these dislodged
blood clots occlude a coronary artery or cerebral blood vessel, they can lead to
myocardial infarction or ischemic stroke, respectively. Approximately one American
every minute will die of a coronary event, and coronary heart disease alone was
responsible for about 1 of every 6 deaths in the United States in 2009 [4].
The internal signaling machinery of platelets allows them to rapidly respond to
changes in their external environment. Platelets do not adhere to an intact vessel wall,
termed the endothelium, in healthy individuals. Following injury to the endothelium,
platelets traveling through the bloodstream can be captured by exposed collagen
mediated by glycoprotein Ib and von Willebrand factor (vWF) multimers. These
interactions result in a platelet monolayer at the wound site, however this monolayer is
insufficient to fully stop bleeding [5].
Extension of a thrombus beyond an initial platelet monolayer is heavily dependent
on platelet-platelet interactions which use fibrin and fibrinogen as a bridge. Recruitment
of additional platelets at this stage is strongly potentiated by local action of agonists such
as ADP or thromboxane A2 (TxA2) which activated platelets release from their storage
granules, and the action of thrombin, a serine protease in the bloodstream which is
initially generated at the injury site following exposure of tissue factor on the damaged
endothelium. These three agonists function by binding to G-protein coupled receptors
(GPCRs) on the platelet surface, activating phospholipase C  which in turn cleaves
inositol 1,4,5-trisphosphate (IP3) from membrane-bound phosphatidylinositol 4,5bisphosphate (PIP2). IP3 triggers Ca2+ release from the intracellular Ca2+ stores [6],
5

causing Ca2+ in the cytosol to rise from resting levels of ~100 nM to as high as 1 M [7].
Collagen itself also causes Ca2+ elevation by signaling through the tyrosine kinase GPVI;
this avenue to Ca2+ release is particularly important as the first monolayer of platelets
deposits at the wound site during clot initiation [8].
A rise in cytosolic Ca2+ has important downstream effects responsible for
changing the platelet’s phenotype to one which is able to participate in and effect the
further extension of a thrombus. Ca2+ mediates Rap1B via Cal-DAG GEF (Ca2+ and
diacylglycerol dependent guanine nucleotide exchange protein) [9] which is a precursor
to integrin αIIbβ3 activation; this integrin binds to fibrin and fibrinogen and so functions
to link platelets to one another during thrombus extension. Ca2+ drives shape change and
spreading at the wound site via activation of myosin light chain kinase which allows for
reorganization of the cytoskeleton [10, 11]. Platelets store agonists such as serotonin,
ADP, and TxA2 in storage granules [12]2 which are released into the extracellular space
following Ca2+ elevation [13, 14]; this leads to localized autocrine and paracrine
signaling events to further drive platelet aggregation. Active platelets expose
phosphatidylserine (PS) on their outer plasma membrane leaflet in a Ca2+ and caspase
dependent manner [15]. This causes the platelet’s surface to take on a negative charge
and be able to serve as a substrate for thrombin generation.
Platelet signaling defects can lead to bleeding diatheses or pathological thrombus
formation. Dysfunctional calcium signaling can lead to pathological thrombus formation
[16] and has also been linked to diabetes [17, 18] and hypertension [19]. Defects or

2

Platelet -granules contain numerous other factors including mediators of hemostasis (factor V,
fibrinogen) but also mediators of angiogenesis (VEGF, PDGF) and cytokines, causing platelets to play
important roles in angiogenesis and inflammation.
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mutations in genes encoding G-protein subunits can lead to impaired platelet aggregation
and prolonged bleeding times [20, 21]. These examples underlie the importance of proper
platelet intracellular signaling in thrombosis.
Platelets act as an ideal system for initial model development primarily due to
their simplicity and availability. Platelets lack a nucleus [22], removing the need to
consider the milieu of transcriptional regulation pathways that are present in the most
other cell types. Platelets are also readily available from healthy donors or patients
exhibiting a particular disease of interest. Many cellular regulatory mechanisms are
highly conserved in biology so that conclusions or predictions drawn from a working
model are often readily extensible to other cell types. An accurate model of platelet
activation also has significance on its own as a predictor of physiologic hemostasis and
pathophysiologic thrombosis.
The signaling cascades involved in the platelet activation process are complex at
both the extracellular and intracellular level. But, as has been seen in many other
biological signaling networks, calcium plays a large role in intracellular signaling and is
involved in a host of critical biological processes [23], frequently serving as the focal
point of a signaling network diagram and thusly represents a natural starting point for a
systems model of platelet metabolism.

1.2 Systems Biology
Cellular systems are incredibly complex with numerous, often competing
reactions occurring simultaneously. Systems biology bridges the junction between
mathematics and biology by applying mathematical modeling techniques to make
7

quantitative predictions about a system’s overall behavior or derive new insights into how
subcomponents of a system interact. As an example, one of the most well studied
phenomena in this field has been E. Coli chemotaxsis which is governed by relatively
few proteins whose interactions have been well characterized [24]. In fact, the
understanding of bacterial chemotaxis has been so well developed that the field has
turned to population modeling. For example, Korobkova et al. [25] combined
experimental measurements and a simple two-state chemoreceptor model [26] to show
that some of the parameters in the chemotactic sensory system are fixed in such a manner
that a bacterial population can respond to chemical signals stochastically and
nonuniformly, and that this type of response has survival value to the group of cells as a
whole.
Much work has also been done on modeling transport into and out of the cell
nucleus via the nuclear pore complex (NPC). A gradient across the nuclear membrane of
RanGTP mediates the specificity of importin and exportin proteins which regulate the
actual transport of compounds through NPCs. This work spanned several groups and
involved several model variants of increasing complexity. The earliest model used
Michaelis-Menten kinetics to simplify several multistep reactions [27]. The next variant
removed the Michaelis-Menten simplifications but only characterized transport by the
RanGTP gradient rather than explicitly modeling fluxes through the carrier proteins [28].
Eventually a more detailed model coupling the RanGTP gradient to the importin system
[29] revealed that the Ran guanine-nucleotide exchange factor (RanGEF), the protein
responsible for converting RanGDP to RanGTP, is not the limiting factor and the
concentration of Ran and other molecules may be more important, settling a point of
8

contention between the prior model variants and revealing to experimentalists which
parameters and species are the best candidates to explore with greater accuracy in the
laboratory. This example illustrates value of more complex models and the collaborative
and sequential nature of model building where models take on greater detail between
generations. Standard model interfaces such as the Systems Biology Markup Language
(SBML) [30] have been developed to facilitate model sharing between groups and the
stepwise process of model development. Subcomponents of cellular machinery separated
on the basis of function, like glycolysis or DNA replication are frequently developed as
distinct computational modules which can serve as parts with which to assemble full
integrative models of cell behavior [31].
Common approaches to modeling cell signaling typically rely on coupled systems
of ordinary differential equations (ODEs) [32, 33] when the cell can be considered a
well-mixed chemical reactor (often broken into subcellular compartments representing
different organelles). Each ODE represents the sum of all rates of change of an individual
cellular component which could be a divalent cation like Ca2+ or an enzyme such as DNA
ligase. The nuclear transport models discussed above were based on coupled ODEs. ODE
systems have the natural benefit of mechanistic detail and are particularly well suited to
the study of systems where kinetic data is available for all state variables and components
under study; these systems can be modeled either deterministically or stochastically [34]
depending on the length scales under consideration. ODE networks have been used to
model GPCR dynamics [35], epidermal growth factor stimulation of mitogen-associated
kinsases [36], regulation of the cell cycle and budding in fission yeast [37, 38], and
phosphoinositide and Ca2+ regulation in human platelets. A multicellular ODE model of
9

pancreatic beta cells, using stochastic modeling of K+ channels, revealed insulin bursting
in as an emergent phenomena resulting from electrical coupling of individual cells [39].
ODEs are by no means the only methods available to systems biologist. When a
sufficient level of topological detail is not available to design a full mechanistic model,
data-driven approaches such as clustering methods, principal components analysis, or
partial least squares regression can be used to derive insight about a system when large
enough datasets are available [40]. Bayesian network analysis [41] can be used to draw
correlations between signaling components, in doing so perhaps directing new avenues of
discovery. One group has used this technique on multivariate flow cytometry data to
make causal predictions of signaling molecule interactions [42]. Neural networks have
been used to incorporate topological and time dependent features of human platelet
calcium signaling to accurately predict responses of platelets simultaneous application of
multiple chemical agonists [43] and have been incorporated into multiscale flow models
of platelet aggregation [44].
Often the emergent or complex system behavior is actually the part of the system
which is experimentally observable. The most relevant example is how the intracellular
calcium concentration, a complex function of the concerted action of channels, pumps, or
buffering agents in cells such as platelets can be quantified by labeling the cells with a
fluorescent, calcium-sensitive dye. In this case the system biologist’s task is to estimate
unknown mechanisms or parameters in the system using the available kinetic and
mechanistic data as a benchmark or guide. This is the “inverse” problem of engineering
new interactions, estimating unknown parameters or reparameterizing measured
parameters whose effective values may be different in the integrated system [45]; often
10

this process must be performed with noisy or incomplete datasets. Global techniques for
parameter estimation and validation which are applied to systems of ODEs or
differential-algebraic equations include particle swarm [46], simulated annealing [47],
and genetic algorithms [48, 49].
Of course, either due to computational limitations or lack of complete datasets,
modeling cells’ entire metabolic states is not feasible. Basic understanding derived from
experiments performed on the system of interest and some biological intuition are
necessary for choosing the most important components to model. To deal with large and
computationally intractable or non-identifiable models, reduction techniques such as
sensitivity analysis [50-52] to determine the species or parameters having the greatest
effects on model outputs, or the time-scale arguments [53] to make simplifying
assumptions can be employed to reduce model size.
Finally, it is important to note the value of integrative, mechanistic or bottom-up
models which have been validated against experimental results is not just to recapitulate
previously observed phenomena, but also to indentify new, experimentally verifiable
hypotheses and thereby make manifest new avenues for research and discovery [33, 40].
Complicated, fine-grained cellular models which can reproduce experimentally measured
behavior approach the pinnacle of becoming reflections of an actual cell. Modelers can
exert precise control over every aspect of these virtual cells; one can easily probe the
effects small changes made to one component may have on other components of the
model, something which may be very difficult to do in live cells. Models can also be used
to discern new candidate signaling pathways for pharmacological treatment, to estimate
the efficacy of existing drugs [54], or to predict potential off-target effects. These are
11

particularly practical applications considering the high cost of drug discovery and
development which has been estimated to cost upwards of $1.8 billion USD per drug
after accounting for cost of capital [55].

1.3 Previous work in modeling platelet intracellular signaling
There are only a few current examples of platelet signaling models in the
literature. One group has modeled thrombin stimulation of calcium release through
PAR1, as well as downstream activation of Akt, PKC, CalDAG-GEF, 2b3, and dense
granule release [56] using ODEs. Purvis et al. [57] developed another ODE model of IP3mediated Ca2+ release stimulated by ADP binding the P2Y1 receptor. This large network
of over 70 species was calibrated [58] by breaking the overall model down into
functionally distinct modules [31], scanning each module’s initial condition space for
configurations satisfying physiologically derived homeostasis constraints, and then
combining each set of solutions into a global initial condition space for the entire system.
The model was also required to be responsive to P2Y1 stimulation. The full model was
able to accurately predict: 1.) steady-state resting concentrations for intracellular Ca2+,
IP3, diacylglycerol, and phosphoinositides. 2.) intracellular Ca2+ transients following
stimulation with doses of ADP, and 3.) the relative volume of the platelet dense tubular
system.
Other modeling approaches in platelets are phenomenological rather than
mechanistic. One data-driven approach has used neural networks to model the response
of calcium over time to multiple stimuli [43]; another group has modeled the action of
12

sodium-calcium exchangers and store-operated calcium entry using very coarse-grained
diffusive mass transfer equations for the transport activity of key calcium channels and
pumps [59]. Such procedures can be very efficient for developing a model which yields a
desired output as they require less knowledge about the underlying reaction topology, but
as they lack molecular detail they are less useful for making novel predictions about the
interactions among system subcomponents.

1.4 Store-operated calcium entry
Store-operated calcium entry (SOCE) is a ubiquitous mechanism that enables
Ca2+ influx into cells from the extracellular fluid, operates in response to Ca2+ store
depletion, and terminates as stores refill [60]. SOCE acts synergistically with Ca2+ release
from stores to elevate cytosolic Ca2+ as well as to allow stores to refill. Most commonly,
store depletion is the result of surface receptor activation leading to IP3 production and
activation of IP3 receptor (IP3R) Ca2+ channels in the endoplasmic reticulum (ER)
membrane (the dense tubular system or DTS is the ER equivalent in platelets). The
phenomenon of store-induced Ca2+ influx was first observed many years ago [61], but the
molecular mechanisms for the process have only more recently begun to be elucidated.
Irreversible SERCA inhibitors such as thapsigargin (TG) which can deplete stores
independently of receptor activation have been instrumental in studying SOCE and led to
the discovery of this type of current in many cell types [60], which many groups have
dubbed “Ca2+ release-activated Ca2+ current” (CRAC).
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Some of the hallmark characteristics of store-operated channels (SOCs), apart
from their unique feature of being regulated by state of the cell’s Ca2+ stores, are 1.) high
selectivity for Ca2+ [62], 2.) high single channel open probability [63], and 3.) low singlechannel conductance [62, 64]. The Ca2+ current through active SOCs is commonly
abbreviated ISOC. siRNA screenings for SOCE inhibitors in HeLa cells led to the
identification of the transmembrane protein STIM1 in 2005 as the calcium sensor
responsible for regulating SOC opening [65]. Embedded in the ER membrane, it contains
a luminal facing EF-hand domain for which Ca2+ serves as a ligand. Loss of bound
calcium results in self-association and translocation of STIM1 to regions of the cell
where the ER membrane and plasma membrane (PM) are in close contact [66-69]. These
aggregates of STIM1 close to the PM are called puncta. Mutations of the EF-hand
domain of STIM1 result in constitutive puncta formation and SOCE channel activation
[65, 66, 70]. STIM1’s Ca2+ affinity has been measured to be between 200 – 600 M [71].
Forster resonance energy transfer (FRET) studies have shown STIM1 oligomerizes prior
to puncta entry [69]. About a year following the initial discovery of STIM1, additional
siRNA screens in Drosophila cells revealed the Orai1 protein3 as being the actual channel
pore-forming subunit in the plasma membrane [73-75]. Mammalian cells possess genes
for two additional variants of Orai [76]. Of these three, Orai1 is the most likely candidate
as the mediator of CRAC on the basis that loss of function mutations in T cells [73] and
mouse platelets [77] largely abolishes SOCE. Orai1 accumulates in puncta over similar
time scales as STIM1 [78].
3

The gene Orai derives its name from Greek mythology where the Orai are the three keepers of the gates
of heaven: Eunomia (Order, Harmony), Dike (Justice), and Eirene (Peace) 72. Homer, R. Fagles, and B.
Knox, The Iliad. 1990, New York, N.Y., U.S.A.: Viking. xvi, 683 p.
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More recent publications have studied the molecular interactions between STIM1
and Orai1. Orai1 has its N and C termini facing the cytosol [79-81]; STIM1 can interact
with both of these domains via its so called Stim-Orai Activating Region (SOAR) in
order to gate the channel [82, 83]. Channel opening occurs in a graded fashion as a
function of the number of STIM1 dimers bound; maximal channel activation requires a
stoichiometry of 4 STIM1 dimers per tetrameric Orai1 complex [84, 85]. High levels of
Orai1 expression can actually reduce ISOC [66, 86-88], possibly be decreasing the ratio of
STIM1:Orai1 and thereby lowering the average channel open probability [85]. Figure 1.1
illustrates the general process of SOCE activation.

Figure 1.1

Mechanism for store-operated calcium entry activation.

In a resting cell, STIM1 and Orai1 are dispersed throughout their respective membranes
(left). Following store depletion, STIM1 loses its bound Ca2+ ligand (right), selfassociates to form dimers, colocalizes with Orai1 at sites of inner membrane and plasma
membrane contact where it can initiate channel opening. Abbreviations: EX: extracellular
space; PM: plasma membrane; CYT: cytosol; IM: inner membrane; DTS, dense tubular
system, the Ca2+ stores of platelets.
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Many studies have shown SOCE playing a direct role in physiologic and
pathophysiologic processes including metastasis [89], endothelial proliferation [90] and
muscle cell contraction and motility [91-93]. In the context of platelets and thrombosis,
mouse platelets lacking STIM1 and Orai1 showed reduced Ca2+ response to collagen and
thrombin and impaired thrombus formation in vitro flow systems [16, 77, 94]. SOCE also
has been shown to be required for PS exposure in agonist-stimulated human platelets
[95]. Ca2+ entry through Orai1 has been shown to induce primary keratinocytes in the
basal epidermis to proliferate and migrate while inhibiting terminal differentiation [96].
Interestingly, STIM1-/- mouse platelets show normal IIb3 activation, aggregation and
degranulation through GPCR-induced store depletion. STIM1 and Orai1 knockout had a
cardioprotective effect in mouse models of arterial thrombosis and ischemic brain
infarction while being associated with only mildly prolonged bleeding times [77]. This
evidence may suggest that in platelets SOCE may play a role in events following the
early events of thrombosis such as thrombus stabilization or clot retraction [97].
So far no group has modeled the complete process for store-operated calcium
entry outlined in Figure 1.1 with mechanistic detail in any cell type. A central portion of
the work in this thesis has been to integrate the current understanding of SOCE into a
previously published model of IP3 mediated calcium release in platelets [57].
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Chapter 2
Model Construction
The regulation of intracellular calcium is essential to numerous cellular processes.
During hemostasis, platelets maintain a low resting intracellular cytoplasmic calcium
concentration ([Ca2+]cyt) as they transit through healthy vessels, yet rapidly activate and
mobilize [Ca2+]cyt to stop bleeding at injury sites. Platelet [Ca2+]cyt mobilization is
associated with integrin activation, dense () and -granule release, thromboxane A2
synthesis, shape change, and phosphatidylserine exposure. Receptor-mediated signaling
through the collagen receptor (GPVI), ADP receptor (P2Y1), thromboxane A2 receptor
(TP), and thrombin receptors (PAR1 and PAR4 in human platelets) results in inositol
[1,4,5]-trisphosphate (IP3)-mediated calcium release from the dense tubular system
(DTS) via IP3-receptor (IP3R) activation. The DTS transmembrane protein stromal
interaction molecule 1 (STIM1) becomes activated as DTS calcium ([Ca2+]dts) drops,
resulting in formation of clusters of STIM1-Orai complexes as the DTS membrane forms
a punctate association with the plasmalemma membrane (PM) containing Orai1. The
STIM1-Orai1 complexes mediate store-operated calcium entry (SOCE) to enhance the
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activation state of the cell. Platelets deficient in SOCE show reduced response to agonistinduced stimulation and impaired thrombus growth and stability under flow [77].
Following stimulus, [Ca2+]cyt is then returned to near-resting levels by the action of two
ATP-dependent pumps, the plasma membrane and sarco/endoplasmic reticulum Ca2+ATPase’s (PMCA and SERCA). The SERCA is responsible for DTS refilling.
A systems biology approach to quantify platelet homeostasis and activation must
consider diverse molecular mechanisms that act in concert to regulate intracellular
calcium. Platelets are an excellent tool for signal transduction studies: they are routinely
available from human donors, lack a genome (obviating the need to predict gene
regulation), are amenable to high throughput experiments, and present numerous
druggable targets. The molecular components of calcium regulation in the platelet include
IP3R, SERCA, calmodulin-regulated PMCA, puncta formation, and STIM1-Orai (Figure
2.1), components that are also well represented in many other cell types. An accurate
model of platelet activation may help predict hemostasis, thrombosis, or drug response.
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Figure 2.1

Overall model topology.

The full model is comprised of 34 species, 35 reactions, 86 parameters and 5
compartments. Three dimensional compartments are: extracellular (EX), dense-tubular
system (DTS) and the cytoplasm. Two dimensional compartments are the DTS inner
membrane (IM) and the plasma membrane (PM). [Ca2+]cyt has a biphasic influence on
IP3R activity; it stimulates IP3R at lower concentrations and becomes inhibitory at high
concentrations. [Ca2+]cyt is also defined as a regulator of puncta formation. The system is
activated by IP3 (blue) which is explicitly controlled as a function of time with
exponential or piecewise polynomial forcing functions.
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In a prior bottom-up ODE model [57, 58], GPCR signaling through P2Y1 activation by
ADP was combined with Gq activation of phospholipase-C, phosphoinositide
metabolism, PKC activation, and calcium release by IP3 and reuptake by the SERCA
pump. With 132 fixed kinetic parameters taken from the literature, this model topology
accurately predicted population and single cell dynamics in the absence of extracellular
calcium influx (as in experiments employing extracellular EDTA). Central to finding
allowable initial conditions for unknown species concentrations, the homeostasis
assumption requires the initial condition to be a steady state solution with low resting
[Ca2+]cyt that also allows responsiveness to elevated IP3. The work presented in this and
the next Chapter [98] extends this model by allowing for external calcium entry.
Calcium entry from the extracellular environment is important for sustained
platelet activation. The present study considers the regulation of calcium flux across the
plasma membrane by store-operated channels (SOCs), which are a calcium channel found
in many excitable and non-excitable cell types [60]. The defining characteristics of SOCs
are: low single channel conductance, high open probability, and high selectivity for
calcium [60]. Known platelet copy number for many of the key constituents [99]
provided a starting point for a high dimensional exploration of the model’s behavior. The
model accurately predicted stable resting [Ca2+]cyt and [Ca2+]dts as well as IP3-triggered
calcium mobilization in both calcium-containing and calcium-free (EDTA) extracellular
buffer. Additionally, the dynamics of DTS membrane-plasmalemma puncta formation
during activation (as a prerequisite for SOCE) was essential to predicting appropriate
platelet characteristics in the presence of extracellular calcium ([Ca2+]ex).
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2.1 Model Construction and Simulation
The set of reactions describing the model topology (see Figure 2.1 and Figure 2.2
and Table 2.1) were modeled as a coupled set of ordinary differential equations (ODEs)
spanning five compartments. For a system with n state variables the governing equations
can be represented as

(2.1)
Each element fi is the sum of all reactions or transport equations which produce, consume
or transport state i. For reactions occurring at compartmental interfaces, concentrations of
species in a two dimensional compartment were scaled to the bulk (three dimensional)
compartment following the procedure described by Kholodenko et al. [100]. Each
compartment was assumed to be well mixed on the basis of the platelet’s small volume (<
10 fL) [101]. Except for specific cases discussed in sections to follow, reactions were
modeled with either mass action kinetics or kinetics similar to Michaelis-Menten. Model
simulations were performed using the SBToolBox2 software package add-on for
MATLAB (The MathWorks, Natick, MA) [102].

2.2 Model Overview
The calcium model (see Figure 2.1) comprises five compartments: the
extracellular space (EX), cytosol (CYT) and dense tubular system (DTS) which are
separated by the plasma membrane (PM) and DTS inner membrane (IM). Calcium is kept
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in balance by four major processes which can be separated into kinetically distinct
submodules shown in Figure 2.2, A–D. In the resting platelet, a low intracellular calcium
concentration ([Ca2+]cyt) is maintained by the action of Ca2+ ATPases in the PM and IM.
The calmodulin (CaM) dependent Ca2+ transporter PMCA (Figure 2.2 C) pumps calcium
into the EX and SERCA (Figure 2.2 A) pumps Ca2+ across the IM into the DTS.
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Table 2.1

Reaction equations, rate laws, and kinetic constants.

All of the model reactions or algebraic equations are presented and grouped according to
the major mechanism which they govern: SERCA, IP3R, SOCE, or PMCA. All fixed
parameters are taken from the references given in the final column and listed below. Rate
constants for STIM1 dimerization and the parameters in the puncta entry Hill function
equation were estimated in the present study.
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IP3R channels (Figure 2.2 B) release Ca2+ from the DTS into the cytosol in response to a
rise in [IP3]. SOCs (Figure 2.2 D) allow calcium entry into the CYT across the PM in
response to store depletion. Calcium pumping via SERCA was modeled using a kinetic
study and model of the SERCA3b isoform [103] which is the most abundant isoform in
platelets [99].
IP3R kinetics are described with a six state model [104] with two active
confirmations that are positively regulated by [IP3] and biphasically regulated by
[Ca2+]cyt. Channel open probability (Po) is based on the total number of tetrameric
channels in either of the two active confirmations (Table 1). For PMCA transport, we use
a kinetic model of PMCA 4b, an isoform abundant in platelets and erythrocytes [99, 105].
PMCA independently and irreversibly transports Ca2+ and if bound to CaM transports
Ca2+ with much higher affinity and turnover rate [106, 107]. The volume of the human
platelet cytosol is ~6 fL [108] and the volume of the DTS has been estimated to range
from 1 – 10% of the cytosol volume by electron microscopy of glucose-6 phosphatase
stained platelets[57, 109].
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Figure 2.2

Submodule schematics and calcium current equation.

(A) SERCA Transport. Subscripts: E1, facing cytosol; E2, facing DTS; P,
phosphorylated. (B) IP3R dynamics. Subscripts: n, native; i1, inhibited; o, open; a, active;
s, shut; i2, inhibited. (C) PMCA Transport. PMCA can irreversibly transport calcium
independently (slow) or with CaM as a cofactor (fast). Subscripts: C, calmodulin bound;
2, two calcium ions bound; 4, four calcium ions bound. (D) SOC assembly and dynamics.
Calcium dissociation results in cytosolic calcium dependent translocation of dimerized
STIM to puncta. STIM in the puncta instantaneously equilibrates with Orai according to a
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set of Monod-Wyman-Changeux (MWC) equilibrium relationships determined by
Hoover et al. [85]. Subscripts: m, monomeric STIM; 2, dimeric STIM. (E) Calcium
current equation. In panels A – D, an arrow with two arrowheads indicates a reversible
reaction while a single arrowhead indicates an irreversible reaction. Red text indicates
calcium is bound. A green outline indicates a channel is open.
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2.3 Modeling ion channel current and membrane potential
The driving force across an ion channel embedded in a biological membrane is
the difference between the electrical potential across the membrane (Em) and the reversal
potential of the ion which is given by the Nernst equation [110]. Net calcium current is
therefore given by Eq. (2.2):

(2.2)

N is the total number of channels per platelet,  the single channel conductance, Po the
channel open probability, and z the number of elementary charges per ion (2 in the case
of calcium). The quantity NA/F (Avogadro’s number divided by the Faraday constant)
represents the number of elementary charges per second per Ampere of current and is
necessary to convert from units of current to moles of calcium per second. In this general
equation, [Ca2+out] represents the calcium concentration in the outer compartment and
[Ca2+in] represents calcium concentration in the inner compartment, e.g. for SOCs
[Ca2+out] = [Ca2+]ex and [Ca2+in] = [Ca2+]cyt. For purposes of determining SOC current, the
product N*Po is equal to the total number of open SOC channels which is obtained from
the MWC equations which will be discussed in Section 2.4.2.
Using the Hodgkin and Huxley framework, the plasma membrane is modeled as
an RC circuit where fluxes of different ions are considered to be a set of resistors in
parallel, we arrive at the following equation for modeling the change in membrane
potential over time [111]:
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(2.3)

Calcium flow across the membrane, ICa, is the sum of all sources of current such as flow
through pumps, channels, or passive leakage. The specific membrane capacitance, CM, is
a relatively conserved quantity across cell types [112] and for this study is estimated to be
approximately 2 F/cm2 based on whole-cell patch clamp measurements that suggest
platelet specific capacitance is somewhat higher than the 1 F/cm2 value typically seen in
other cell types due to platelets’ extensive surface invaginations [113]. Resting potential
across the plasma membrane is maintained by voltage-dependent K+ channels and has
been estimated with voltage sensitive fluorescent dyes to be between -60 and -70 mV [6,
114, 115]. In practice in human platelets, plasma membrane potential (VPM) is fairly
constant during platelet activation by common agonists [115]. The resting potential
across the DTS membrane (VIM) is much less certain and remains unmeasured. The fact
that slow calcium leakage from the endoplasmic reticulum is observed in the presence of
SERCA inhibitors implies resting VIM is more inside negative than the reversal potential
of Ca2+ across the IM. Assuming a resting [Ca2+]dts of 300 M, VIM must be greater than 100 mV [116]. Experiments in mouse pancreatic acinar cells [117] and rat sensory
neurons [118] in which [Ca2+]cyt was held constant with a BAPTA/Ca2+ buffer solution,
calcium stores were depleted using SERCA inhibitors and store Ca2+ content measured
with Mag-Fura2 found that stores plateau at a level greater than clamped [Ca2+]cyt.
Assuming these plateaus are the result of net zero flux out of IM Ca2+ channels, from Eq.
(2.2) one can calculate a VIM as high as -74 mV.
29

2.4 SOCE Modeling
Several important features of SOCE have only recently been elucidated. SOCE
activation consists of the calcium sensor STIM1 [65, 119] unbinding Ca2+ from its DTSfacing EF hand domain when [Ca2+]dts drops relative to its Kd. Calcium unbinding allows
STIM1 oligomerization, translocation to regions of the DTS membrane in close
opposition to the plasma membrane, and finally association with tetrameric [120, 121]
Orai1 protein channels in the PM. Orai1 passes current when at least one dimer is bound.
We model the active form of STIM1 as a STIM1 dimer (STIM2) and model the first two
steps using mass action kinetics. STIM1 dimerization is assumed to be diffusion-limited.
Patch clamp studies on larger mammalian cells indicate that store-operated current is
inwardly rectifying, i.e. that the channels only allow current into the cell and do not
operate in reverse under physiological conditions [122]. Platelets possess several other
isoforms of STIM and Orai [99, 123]. Of these, STIM1 and Orai1 are the best studied and
they are the most likely candidates for the components of functional SOC channels. For
the purpose of this study, we refer to STIM1 and Orai1 as simply STIM and Orai.

2.4.1 Puncta formation
STIM and Orai are localized in separate membranes that require close contact for
SOC activation [81, 124]. Store depletion causes STIM and Orai to undergo a
rearrangement from being diffusely distributed in their respective membranes to a colocalized state at junctions between the IM and PM called puncta [65]. STIM can enter
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the puncta by two mechanisms. One is passive diffusion (D ~ 0.1–0.15 m2/s) [69]. This
mechanism accounts well for the time lag between STIM oligomerization and puncta
formation in larger mammalian cells [125], however platelets are small enough that
timescales for diffusion limited translocation would be < 1 s. When STIM puncta entry
was modeled in this fashion (i.e. STIM in the puncta is essentially equal to total bulk
STIM due to fast diffusion), we observed that the simulation could not satisfy
homeostatic constraints on calcium while simultaneously observing significant
contribution of SOCE to [Ca2+]cyt following IP3 stimulus. Thus, we modeled STIM2 entry
into the puncta with a [Ca2+]cyt-dependent Hill function applied to bulk IM STIM2.
(2.4)

(2.5)

Only STIM dimers (STIM2) are allowed to enter the puncta on the basis of evidence that
STIM oligomerization precedes puncta formation [125]. Eq. (2.5) effectively reduces the
amount of STIM2 available for binding to Orai as only STIM in the puncta ((STIM2)p) is
able to interact with Orai. The parameter α represents the maximum fraction of STIM2
that can enter the puncta and was set to 0.2. KM is the value of [Ca2+]cyt at which p is
50% of its maximum value; n is the Hill coefficient. The offset of 0.01 is needed to
prevent p being much less than unity at rest; p << 1 would lead to scenarios where
[Ca2+]cyt is the more dominant regulator of SOCE activity than [Ca2+]dts which goes
against the current understanding of the process. This regulation could represent an
unidentified scaffold or helper protein that is regulated by [Ca2+]cyt and necessary for
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STIM2 puncta entry. Alternatively it also could represent an increase in the amount of
surface contact between the IM and PM as a result of actin-dependent cytoskeletal
reorganization [126].
2.4.2 Channel Assembly
A recent study employing Orai tetramers fused with variable numbers of STIM
dual C-terminal domains has shown a graded relationship between the number of STIM2
bound and the activation state of the SOC channel [84]. To model association of
(STIM2)p with Orai, we adopt a similar Monod-Wyman-Changeux (MWC) [85, 127]
equilibrium framework to model cooperative ligand binding. Channels exist in four states
having 0 to 4 STIM2 ligands bound. Each channel state can either be open (O, OS, OS2,
OS3, OS4) or closed (C, CS, CS2, CS3, CS4). (STIM2)p binds to Orai tetramers with
negative cooperativity and channels open with positive cooperativity as a function of the
number of (STIM2)p bound. To satisfy mass balance all channel states (open and closed)
must sum to the number of Orai tetramers. All states have the same conductance, but only
open channels can pass current. At any given instant, not all (STIM2)p is bound to Orai.
The concentration of (STIM2)p accessible to (i.e. in the puncta) but not bound to Orai is
called Sf and is obtained by mass balance. Figure 2.2 D shows the possible transitions
that can occur among these 10 states; the equations corresponding to these relationships
are given in Table 1. General equations to represent the equilibrium relationships are

(2.6)

In these equations, L is the intrinsic opening equilibrium constant, Ka is the association
constant for (STIM2)p binding Orai, a is the binding cooperativity factor, and f is the
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opening cooperativity factor [85]. Similar equations can be written for the closed states.
The values for fixed parameters f, a, Ka and L were selected to yield an average open
probability of ~0.8 at saturating levels of STIM2 (see the Supporting Information of [85])
based on the results of noise analysis performed in store-depleted Jurkat T cells [63].
Following a procedure similar to that of Hoover et al., we generated analytic solutions to
these 9 nonlinear equations coupled with mass balances on total (STIM2)p and Orai using
the MATLAB Symbolic Toolbox; these equations are listed in Appendix A. These
algebraic equations are in terms of Orai and Sf. However at model runtime it is Orai and
(STIM2)p that are known from the kinetic equations discussed in previous sections. We
used a linear set search algorithm to search for values of Sf which give the correct
solutions for sets of pairs of Orai and (STIM2)p. The result was a two dimensional lookup
table (LUT) that returns Sf as a function of Orai and (STIM2)p. Linear interpolation is
used to calculate Sf at points not recorded in the LUT. Using a LUT in this way is much
faster than having to search for the value of Sf that solves the equations given [Orai,
(STIM2)p] at every time step of a simulation despite the significant extra memory
overhead that is involved. With Sf in hand, the channel states can be calculated from the
analytic solutions to the MWC equations. Figure 2.3 A – E illustrate the evolution of SOC
states as a function of (STIM2)p and Orai.

33

Figure 2.3

Analytical solutions to MWC equations as a function of interacting
Orai and STIM dimers.

(A – E) These panels present the distribution of SOC states with 0 – 4 STIM ligands
bound for variable numbers of Orai tetramers and STIM dimers. To determine these
quantities, Sf is estimated at each [Orai, (STIM2)p] pair from the LUT and the channel
states are calculated using the expressions in Appendix A. (F) Pavg as a function of Orai
tetramers and STIM dimers. The line [STIM12] = 4[Orai] in the STIM-Orai plane is
34

overlaid in blue. When STIM2 is greater than 4 times the number of Orai tetramers, all
SOCs exist with four STIM2 ligands bound and Pavg becomes equal to Po4.
The open probability of channel state i is the ratio of the open channels in state i
divided by the total number of channels in state i

(2.7)

and is a fixed quantity for each channel state. The second equality in Eq. (2.7) comes
from substituting in the appropriate expressions for OSi and CSi which are given in
Appendix A. Table A.1 lists these values.

SOC channel state Po
Po0
Po1
Po2
Po3
Po4

Table 2.2

Value
0.00001
0.00142
0.0198
0.223
0.803

Individual SOC channel state open probabilities.

Presented are the open probabilities of the tetrameric Orai channels with zero to four
STIM dimer ligands bounds. Po values are calculated according to Eq. (2.7). In the model
Po0 is rounded to zero.
Average open probability (Pavg) is the sum of all open channel states divided by
the total number of channels (i.e. the number of Orai tetramers) and is shown in Figure
2.3 F. When (STIM2)p = 0, Pavg is zero as all channels have zero (STIM2)p bound. As the
amount of (STIM2)p exceeds Orai by four fold (indicated by the blue line), all channels
exist with four STIM2 ligands bound and Pavg = Po4 ~ 0.8.
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For purposes of modeling net current, or calcium flux, through SOCs we need
only know the total number of open channels. Figure 2.4 A illustrates the relationship
between the total number open channels and (STIM2)p and Orai. The total number of
open channels, that is

is equivalent to the quantity NP0 in Eq. (2.3). Figure 2.4 B illustrates the general
procedure for SOCE current (ISOC) calculation. Because SOC current is inwardly
rectifying [62, 122], in our model we do not allow SOCE to pass current in the reverse
direction (i.e. out of the cell, which otherwise could occur in simulations run without
Caex).
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Figure 2.4

SOCE current determination.

(A) The total number of open SOCs is determined by the MWC equations as a function of
STIM2 in the puncta and Orai. (B) Procedure for determination of SOCE current. At
every given time step in a simulation, the amount of STIM2 in the puncta is determined
by kinetic rate laws and Eq. (2.4). These quantities are passed to a pre-generated lookup
table, presented as a surface in panel A, which yields the total number of open channels
used in the equation for store-operated current.

2.5 IP3 forcing function
Common platelet activation signaling pathways lead to PLC mediated hydrolysis
of PIP2 to produce IP3, the IP3R channel mediator. Agonist stimulated generation of IP3 is
well studied [128, 129]; previous work has modeled ADP mediated Ca2+ release via the
G protein-coupled receptor P2Y1 [57]. For the present study in which we explore
combined IP3-mediated and SOCE regulation of intracellular calcium, we removed
upstream pathways leading to IP3 generation in order to simplify the modeling process
and reduce the number of unknowns requiring estimation. Thus instead of [IP3] dynamics
being governed by a reaction network, we impose an explicitly defined supply of [IP3] as
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a forcing function over time in order to simulate an activated platelet. To model [IP3]
over time we fitted experimental human platelet [IP3] time course data [130] using a
cubic Hermite interpolant [131]; this is a type of spline fit designed to minimize
oscillations between data points. In the fitting data, values were only recorded to 30s
post-stimulation. Platelet calcium dynamics typically occur over timescales longer than 1
minute; therefore time points greater than 30 s were extrapolated. Prior to fitting, the data
was normalized by the resting value at t = 0 s. The general shape of the [IP3] versus time
curve, particularly in the region based on extrapolated data points, was loosely based on
the results of previous modeling work [57]. In the final fit, IP3 rises to about 5 fold higher
than its resting value within 5 s of stimulation, and returns to a new steady level within
200 s. Other [IP3] measurements in human platelets stimulated with a high dose of
thrombin [132] also present a similar fold increase in [IP3], indicating that a 5 – 6 fold
increase may represent a saturating limit of the phosphoinositide pathway. Figure 2.5
illustrates the forcing function; this function was used for the parameter scans discussed
in Chapter 3.
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Figure 2.5

Spline fit IP3 forcing function.

Normalized [IP3] versus time data recorded in human platelet preparations stimulated
with ADP at t = 0s were fitted with a cubic Hermite interpolating polynomial. Data points
for fitting at t > 30s were estimated based on previous modeling of ADP mediated IP3
generation.

For the IP3 dose response simulations discussed in Chapter 3 in which it was
desirable to have more precise control over the shape of the curve we cast [IP3] as an
exponential function of time. For an IP3 dose delivered at t = 0 s, this equation is
(2.8)

This equation is able to generate curves with shapes similar to the fit in Figure 2.5. The
expressions in this equation and values for the fixed parameters a, b, and c as well as the
exponent of 0.6 were determined through trial and error. The second rational function
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term is present to allow [IP3] to settle to a value higher than baseline at long times. For
both types of fits, the initial level of IP3 ([IP3]0) varies with the model resting state.
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Chapter 3
Steady-state kinetic modeling of regulators of
calcium homeostasis
Computational models are useful for quantifying large reaction networks in
complex biological systems [36, 58, 133, 134] which often exhibit very nonlinear
behavior which makes them difficult to solve analytically or to predict using intuition.
While data on reaction mechanisms, rate constants, and other physical parameters are
frequently available in databases or scientific publications [135-137] (also see Table 2.1),
integrating individually studied mechanisms to gain a systems level understanding of a
model can be quite challenging. This is partly because such mechanisms are often studied
ex vivo or in isolation. For example, the kinetic properties of SERCA have been assessed
by isolating vesicles from COS-1 or HEK-293 cells engineered to express human SERCA
2 and 3 isoforms [103, 138]. One can imagine how the effective kinetic properties of such
a complex protein may be different when observed in an environment outside the normal
cellular milieu.
Thus one of the challenges of systems biology is tuning often large sets of
parameters to get a model of integrated biological mechanisms to behave in a way which
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is consistent with available experimental data; only after a model is so calibrated can it be
expected to make realistic quantitative and qualitative predictions4 [139]. In this context,
“parameters” can also include diffusible species concentrations or protein copy numbers
(i.e. elements of a model’s initial condition vector). An additional hurdle is datasets
themselves are often noisy or incomplete.
Numerous parameter estimation algorithms have been developed. These can fall
into the category of being local or global. Local methods such as Nelder-Mead Simplex
or Levenberg Marquardt [140] are less computationally demanding but are inappropriate
for systems with complex objective function landscapes as they will (relatively) quickly
converge to a local minimum [45, 141]. Methods can also be classified as deterministic or
stochastic. Stochastic methods which randomly sample initial condition/parameter spaces
for starting points are much less computationally demanding than deterministic methods
but are also not guaranteed to reach a global minimum; such an uncertainty can usually
be minimized for most problems when one allows for a reasonable number of samplings
of state space. Some examples of stochastic global algorithms include particle swarm,
simulated annealing, and genetic algorithms [45].
The behavior of complex, interconnected reaction networks is often more
sensitive to models’ initial conditions rather than to topology or fixed parameters [142].
Species concentrations may be expected to be more variable in nature as well. While rate
constants are largely fixed by genetics and should be constant across healthy populations
(genetic mutations are a notable and clinically relevant exception to this), stochastic

4

This ignores the commonly encountered problem of overfitting, where a model has been optimized to fit
a set of data very well but is not robust to state changes or is unable to predict the results of other related
experiments.
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variations at the molecular level in processes like transcription and translation can result
in individual cells of the same type with different distributions of molecular constituents.
As cell division results in some memory in the daughter cells as to the molecular makeup
of the parent cell, these stochastic variations can manifest at the organismal level. We can
use the platelet as a specific example. Platelets are formed by “blebbing” off from larger
megakaryocytes in the bone marrow [143]. During this process, it is reasonable to
imagine individual platelets acquiring different copy numbers of proteins and other
biological molecules. Recent modeling work has suggested that the stronger response of
platelets to thrombin versus the weaker agonist ADP can largely be explained by
differences in copy numbers of their respective receptors [57], as the intermediate
signaling steps leading to calcium mobilization are otherwise very similar for these two
agonists. Thus the parameter scanning procedure discussed in the following sections
primarily seeks to explore the effect of varying species concentrations and protein copy
numbers on model’s behavior.

3.1 Introduction: Platelet Calcium Balance
At rest, the platelet maintains stable sub-micromolar levels (40 – 100 nM) [6] of
cytoplasmic calcium in balance with: nanomolar levels of IP3 [132, 144, 145], high submillimolar storage pool calcium levels (100 to 400 M) [146], and millimolar
extracellular calcium (~ 1.5 mM) [147]. In achieving calcium homeostasis, the cell must
balance the four interacting molecular modules: IP3R, SERCA, PMCA, and SOCE.
Additionally, at the moment of GPCR activation, the dynamics of IP3 synthesis and
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conversion mediate a large increase in intracellular calcium that is typically partially
restored to resting levels while the calcium store refills following store operated calcium
entry.
Several constraints must be simultaneously met by a dynamic model of calcium
regulation. The model must:
1) Maintain low cytoplasmic calcium at rest in the presence of finite IP3 levels.
2) Maintain high store concentration at rest, even in the absence of extracellular
Ca2+.
3) Present an increase in cytoplasmic calcium following stimulation.
4) Refill the store following transient cellular activation.

To meet these requirements in the resting cell the system is in a state of dynamic
equilibrium; PMCA pumping out of the cell must equal SOCE flux into the cell. Also at
rest, IP3R flux must equal SERCA pumping. Importantly, placement of EDTA (calcium
chelators) outside a cell must not cause a rapid depletion of store calcium. For example,
platelets sitting in EDTA for an hour can still mobilize calcium following agonist
stimulation. For platelets, resting cytosolic calcium is ~25 to 100 nM [7, 101] and DTS
calcium is ~250 M [146]. At resting [Ca2+]cyt, SERCA likely cannot pump against
concentrations higher than 500 M Ca which places an upper limit on store Ca2+ levels
[148]. In the following two sections we present and apply a numerical method to
investigate which sets of initial conditions allow the platelet calcium model to satisfy the
above four homeostatic and dynamic constraints.
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3.2 Monte Carlo method for exploring topologically enforced
homeostatic constraints
Common stochastic parameter estimation routines are very abstract in that they
view the problem as a black box by minimizing an objective function quantifying the
difference between model output (or multiple outputs) and set(s) of data. The method
used here is different in that it exploits the system’s programmed physiology to search for
resting configurations which are candidates for viable models. This method has the
advantage of being completely independent of experimental time course data.
Where data on the cell’s resting state is unavailable, intuition can be used to
estimate a feasible sampling range. For example, a cell can reasonably be expected to
have at least one copy of a protein. Similarly, a cell can only fit so many molecules inside
itself. For example, assuming a spherical platelet of 3 m diameter and an average
transmembrane protein cross-sectional size of 35 nm2, fewer than 200,000 proteins could
fit into the plasma membrane. These arguments are simplistic and ignore the presence of
other proteins (or even phospholipids in the case of our membrane example) in the
system but are still useful as an order of magnitude estimate on the upper bounds for
sampling ranges.
With a sampling space established, samples can be randomly drawn from this space
and passed as initial conditions to the model and the model simulated until reaching
steady state. Note that this parameter estimation scheme applies just as well to fixed
parameters; these quantities can be considered to be state variables whose rate of change
is zero. This scheme is summarized in Figure 3.1.
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Figure 3.1

Monte Carlo state and parameter space scanning routine.

First one defines a physiologically derived sampling space with a number of dimensions
equal to the number of unknowns in the system. Initial conditions (and parameters) can
be drawn from this space, and the model is simulated to steady state. This gives the
modeler a set of resting configurations which can then be further analyzed or filtered
based on static or dynamic criteria.
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To apply this method to our model, we densely sampled a 12-dimensional space
of several protein species (IP3R, SERCA, STIM, Orai, CaM, and PMCA), non-protein
species ([Ca2+]cyt, [Ca2+]dts, [IP3]), VIM, and two unknown fixed parameters (Km, n) in the
model (see Table 3.1). For proteins, the search space was in a local region constrained by
available LCMS data [116]. In general, copy numbers were allowed to vary by a factor of
2 above and below the measured values. All other rate parameters were fixed. VPM was
set to -60 mV [114] and [Ca2+]ex to 1.2 mM. Resting states were accepted based on
[Ca2+]cyt, [Ca2+]dts and [IP3] satisfying the physiologic constraints outlined in the column
“Acceptance Criteria” in Table 3.1 and discussed in Section 3.1. There is no need for
acceptance criteria to be placed on the total protein counts as there is no protein
generation or degradation present in the model.
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State/Param (units)

Known Values

Sampling Range

Acceptance
Criteria

Reference

Cacyt (nM)

75

10 – 100

25 – 100

Siess, 1989, [7]

Cadts (M)

250

80 – 1000

100 – 400

Sage, 2011, [146]

IP3 (nM)

~ 130

20 – 200

 1

Nakagawa, 2002, [145]

IP3R (copies/cell)

1,700

850 – 3,400

Burkhart, 2012, [99]

SERCA (copies/cell)

16,300

4,600 – 18,400

Burkhart, 2012, [99]

STIM (copies/cell)

3,700

1,850 – 7,400

Burkhart, 2012, [99]

Orai (copies/cell)

425

212 – 850

Burkhart, 2012, [99]

CaM (copies/cell)

15,600

7,200 – 32,500

Burkhart, 2012, [99]

PMCA (copies/cell)

640

320 – 1,280

Burkhart, 2012, [99]

VIM (mV)

> -100 mV

-100 – -60

Burdakov, 2005, [116]

KM (nM)

100 – 300

This study

n

1–3

This study

Table 3.1

List of 12-dimensional state space sampling ranges.

The sampling space is chiefly derived from literature measurements. The units listed in
parentheses in the first column also apply to values in the following three columns.
Protein copy numbers ranges were generally set with upper and lower bounds 2-fold
above and below mean values measured by LCMS. The acceptance criteria for [Ca2+]cyt
and [Ca2+]dts are unequal to the sampling ranges because these species quickly get bound
to proteins like SERCA or STIM1 or transported to other compartments after the model is
initialized with a random initial condition vector making their final resting values
oftentimes very different from their initial values; the sampling ranges were adjusted
based on these facts to make it easier to find resting configurations satisfying the
acceptance criteria. The acceptance criterion for IP3 exists to ensure the number of IP3
copies is greater than unity.
We accepted a sample as being at steady state if the relative absolute value of the -norm
of the rate of change vector was less than 0.1%. Expressed mathematically:
(3.1)
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We did not consider configurations which exhibit oscillations; the number of such
configurations which demonstrated oscillatory behavior was quite few (< 0.1% of steady
states sampled).

3.3 Results
3.3.1 Filtering configurations based on robustness and dynamic
constraints.
A dense sampling of over 2.6 million initial conditions from this 12-dimensional
sampling space produced 150,000 steady states which satisfied the homeostatic
requirements that were enforced. An important additional resting criterion is that states
remain stable upon Caex removal; this is particularly important in the context of our
modeling as Caex chelation is an important experimental technique for measuring the
contribution of extracellular calcium entry (e.g. SOCE) to the overall Ca2+ response. To
apply this condition we selected for states that exhibited less than a 5 M decline in
[Ca2+]dts over 333 s following Caex removal. This constraint is supported by experiments
in which cells did not respond to calcium re-addition after having been stored in EDTA
for more than 10 minutes (implying their stores were not significantly drained) [149].
The set of accepted resting states were further characterized and grouped based on
their responses to a 5.5-fold IP3 stimulus (see Section 2.5 of Chapter 2). First,
configurations were filtered for those that were responsive to IP3 based on peak [Ca2+]cyt
reaching a concentration greater than 200 nM following IP3 application. Second,
configurations were filtered for those that also showed SOCE activity. This criterion was
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based on difference in peak [Ca2+]cyt in simulations with and without Caex reaching a
value greater than 100 nM. We chose to use [Ca2+]cyt as the metric for SOCE activity as
this quantity is commonly measured and numerous data in the literature point to a
substantial difference in [Ca2+]cyt in human platelets labeled with fluorescent dyes
following agonist stimulation with and without Caex present [126, 150, 151]; the value of
100 nM was based on the measurements of one study in particular which used ADP
[150], a weaker platelet agonist. These filtering criteria and the number of resting states
which satisfy each are tabulated in Table 3.2. In the analysis and discussion to follow
these filters are applied sequentially such that configurations falling into the last group
listed in Table 3.2 also satisfy all the other conditions. Notably, less than 0.06% of all
sampled initial conditions satisfied all 4 homeostatic and dynamic constraints which
indicates the system is well constrained by these criteria.

Condition

Mathematical constraint

Steady State Calcium

25 nM  Cacyt  100 nM,
100 M  Cadts  400 M

States

Percent

150,000

5.64%

18,932

0.71%

8,093

0.30%

1,513

0.06%

Resting DTS leak
Stable in EDTA

Active

< 0.015 M/s
Max(Cacyt) > 200 nM with IP3
(Max(Cacyt) in +/-EDTA)

SOCE
> 100 nM

Table 3.2

List of resting configuration filtering constraints.

Resting configurations were divided into groups based on: (1) resting [Ca2+]cyt and
[Ca2+]dts being within physiologic ranges; (2) calcium levels being stable upon Caex
removal; (3) active states in which [Ca2+]cyt rises above 200 nM following 5.5-fold IP3
stimulus; (4) difference in [Ca2+]cyt following 5.5-fold IP3 stimulus with and without Caex
is at least 100 nM. Constraints are applied sequentially, e.g. resting configurations
satisfying the SOCE constraint also satisfy those constraints listed in the rows above.
Percentages are relative to the initial set of 2.6 million resting configurations.
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Figure 3.2 presents the probability distributions of each search dimension for the three
filtered

populations

(i.e.,

functional

phenotypes)

of resting

initial

condition

configurations. The filter is indicated by the shaded circle and corresponds to the
descriptions in Table 3.2. Where applicable, an arrowhead indicates measured resting
values. The model topology and parameterization and filtering criteria placed sufficient
constraint to push resting [Ca2+]cyt, [Ca2+]dts to the lower end of the search range. Platelets
that met all criteria had IP3 levels constrained fairly narrowly between 20 and 40 nM (<
200 copies per platelet), somewhat lower than the measured 130 nM value [145]. The
model accepts lower [Ca2+]dts than the measured value of ~250 M [146]. This is likely
due to the constraints our sampling ranges have placed on the ratio of SERCA to IP3R.
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Figure 3.2

Resting configuration probability distributions.

Probability distributions of model species and parameter configurations satisfying the
“Stable in EDTA”, “Active” and “SOCE” filtering constraints. All distributions also
satisfy the “Steady State Calcium” criterion. An arrow at the top of the first bar for
protein species indicates the experimentally measured protein copy numbers [99].

Currently, no experimental measurements of VIM exist due to technical difficulties in
measuring potential across the ER membrane using patch-clamp. We allowed our scans
to sample VIM in the range of -100 to -60 mV based on arguments in the Section 2.3.
Model configurations stable in EDTA show a lower (i.e., more negative) inner membrane
potential however, in stark contrast, configurations that are responsive to IP3 as well as
those which also demonstrate SOCE posses a higher VIM that clusters near the upper
bound of the sampling range. The parameters n and KM which govern STIM entry into
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puncta appear to become more monodisperse as additional filtering conditions are
applied.

3.3.2 Transient behavior following IP3 stimulus
Calcium release from the stores requires transient stimulation of IP3R by IP3.
Literature measurements of IP3 time courses in human platelets stimulated by strong
doses of agonists such as thrombin and ADP show [IP3] rising sharply by several fold and
peaking within 2.5 – 30 s following agonist delivery [132, 144, 145]. Furthermore, [IP3]
and [Ca2+]cyt return to nearly resting levels 30 – 60 s following agonist stimulation [130]
as IP3 is degraded by phosphatases and Ca2+ is pumped back into the DTS. Figure 3.3
shows the response of a subset of the fully filtered population of resting states to an IP3
stimulus constructed to mimic these measured behaviors (see Section 2.5).
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Figure 3.3

Representative model responses to IP3 stimulus.

15 resting states satisfying all filtering criteria were stimulated with 5.5 fold IP3 dose
starting at t = 20 s. The IP3 doses are illustrated in the inset in the upper right panel. (B)
Calcium traces for DTS and cytosolic Ca2+ of a representative configuration taken from
this population to the six IP3 doses shown in the inset in the upper right panel. The colors
of the curves correspond to the IP3 dose. Left column: [Ca2+]ex = 1.2 mM; right column:
[Ca2+]ex = 1 pM.
[Ca2+]cyt generally peaks within 15 – 20 s of IP3 application (the [IP3] time courses which
are shown in the inset peak ~3 s following application), and reaches a higher peak and
remains more sustained in the presence of extracellular calcium. [Ca2+]dts partially refills
in simulations run with Caex and shows no refilling in calcium-free media. [Ca2+]cyt peaks
earlier in simulations without Caex; this is due to SOCE continuing to be partially active
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as stores refill rather than there being a time delay in ISOC activation following store
depletion (see Figure 3.6 A).
Figure 3.4 B shows the calcium responses of a representative configuration from
the stable population to a series of increasing [IP3] stimulations shown in Figure 3.4 A.
The 1.5x and 2x stimulations were too weak to elicit substantial SOCE; at higher IP3
doses, stores become depleted enough that SOCE manifests itself via elevated [Ca2+]cyt
and substantial store refilling. The model predicts faster time to peak [Ca2+]cyt at stronger
IP3 doses in –Caex simulations; in contrast, in +Caex simulations peak [Ca2+]cyt is higher
and delayed until stores refill to sufficiently inactivate SOCE (also see Figure 3.6).
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Figure 3.4

Response of population stable in EDTA to a dose of IP3.

(A) The population of states satisfying the stability criterion (n = 18,932) were stimulated
with a dose of IP3 which is summarized as a percentage increase over baseline. The IP3
stimulus begins at 10 s. (B) Calcium traces for DTS and cytosolic Ca2+ of a representative
configuration taken from this population to the six IP3 doses presented in panel A. The
colors of the curves correspond to the IP3 dose. Left column: [Ca2+]ex = 1.2 mM; right
column: [Ca2+]ex = 1 pM. (C) Distributions of peak [Ca2+]cyt for each IP3 dose. The black
vertical dotted line indicates mean resting [Ca2+]cyt and the red dotted line indicates our
cutoff for a configuration to be considered “responsive” to stimulus. The number and
percentage of configurations satisfying this criterion are indicated in red in the upper
right of each histogram. Increasing the IP3 dose makes more states satisfy this criterion;
in addition peak [Ca2+]cyt largely saturates beyond 5x IP3.
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Figure 3.4 C shows histograms of peak [Ca2+]cyt of the entire set of stable configurations
(n = 18,932) following application of each dose of IP3 in panel A. Stronger doses of IP3
predictably result in higher average [Ca2+]cyt; this effect saturates past 5x IP3.
Figure 3.5 compares the model’s [Ca2+]cyt response to the 10x IP3 stimulation
(left) with experimental time course data (right) from human PRP fluorescently labeled
with fura-2 and treated with 40 M ADP at t = 20s [150]. The simulations generally
agree very well with the experimental data; there is a small time delay of ~20s in peak
[Ca2+]cyt in the +Caex simulation compared to experiment; this time delay is reproducible
using other model initial conditions (data not shown).

Figure 3.5

Comparison of model output with experimentally measured calcium
transient.

The 10x IP3 simulated [Ca2+]cyt time course from Figure 3.3 B (left) is compared with
calibrated fura-2 time course data in human platelets treated with 40 M ADP at t = 20 s
(right) [150].
To attempt to explain the source of this time delay, Figure 3.6 A plots simulations of Ca2+
flux via PMCA (blue curve) and SOCE (red curve) following a 5.5x IP3 dose applied at t
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= 10s. The corresponding [Ca2+]cyt and [Ca2+]dts traces are shown in Figure 3.6 B with
peak [Ca2+]dts and [Ca2+]cyt times indicated by the bolded solid and dashed lines,
respectively. SOCE flux peaks at the time [Ca2+]dts reaches its minimum. This implies
there is no delay in SOCE activation with respect to [Ca2+]dts. As stores do not refill
immediately, there is a slow inactivation of SOCE current which continues to drive
[Ca2+]cyt higher even after the stores have finished emptying; [Ca2+]cyt does not peak until
the SOCE flux is nearly overtaken by the PMCA flux out of the cell.

Figure 3.6

Time delay in +Caex simulations is due to slow SOCE inactivation.

(A) This panel plots Ca2+ flux across the PM, the blue curve being Ca2+ flux out of the
cell via PMCA, and the red curve Ca2+ flux into the cell via open SOCs. ISOC peaks at
about the time when [Ca2+]dts reaches its minimum value (peak time indicated by a
vertical solid black line). [Ca2+]cyt does not peak (peak time indicated by a vertical dashed
black line) until the extra Ca2+ influx into the cytosol is reduced to near zero by PMCA.
(B) Calcium traces of [Ca2+]cyt and [Ca2+]dts corresponding to the simulation shown in A;
each are normalized by their maximum value. The bolded vertical lines are the same as in
panel A.

In Figure 3.7, model configurations in the stable in EDTA population were
subjected to a 10x IP3 dose at t = 0 s with [Ca2+]ex set to 1.2 mM. Panel A shows no
correlation between the time at which [Ca2+]cyt reaches its peak and fractional store
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refilling. Panel B shows that the peak [Ca2+]cyt time decreases as the SERCA to IP3R ratio
increases. As SERCA and IP3R act in direct opposition to one another, configurations
with a higher SERCA / IP3R ratio are able to refill stores more quickly.

Figure 3.7

Rate of store refilling is an important determinant of peak [Ca2+]cyt
time in +Caex simulations.

(A) Scatter plot of the time at which [Ca2+]cyt peaks versus fractional amount of store
refilling reveals no correlation between the metrics. Fractional refilling is calculated as
the final value of [Ca2+]dts in a simulation divided by the initial drop following IP3
stimulus. (B) Scatter plot of the time at which [Ca2+]cyt peaks versus the SERCA / IP3R
ratio.

3.3.3 Perturbation of the fraction of STIM able to enter puncta
Next we explored the effect altering fixed parameters governing SOCE would
have on the model’s steady state and dynamics following stimulus. An in silico
experiment like this is very much analogous to simulating the effect of a mutation in a
gene. Genetic mutations can often have disastrous consequences for the organism. For
example, mutations in the HEX A gene encoding the lysosomal protein hexosaminadase
A result in a nonfunctional enzyme which is unable to remove an amino sugar residue
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from GM2 gangliosides, leading to a dangerous buildup of this compound in the brain
[152]. These mutations are associated with Tay-Sachs disease.
For the work presented here, we focused on the parameter  which establishes the
maximum fraction of STIM2 that can enter the puncta (see Eqs. (2.4) and (2.5)). Mutation
of the glutamate or aspartate residues responsible for Ca2+ binding in the STIM EF-hand
domain leads to constitutive puncta entry and associated higher basal ISOC [65, 86].
Following perturbation and after allowing for an adjustment phase of at least 200 s, the
model was checked for being at steady state as per Eq. (3.1). The perturbations were
performed on the resting configurations that satisfied all filtering conditions (n = 1,513;
also see Section 3.3.1).  was perturbed from 0.2 (the initial value for all configurations)
to 0.5, 0.75 and 1.
In Figure 3.8 we present resting [Ca2+]cyt (left) and [Ca2+]dts (right) distributions
following parameter perturbation.
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Figure 3.8

Resting Ca2+ for the state population satisfying all resting and
dynamic constraints following  perturbation.

The fixed parameter  was altered to the levels indicated for the population of
configurations that were stable in EDTA. The Ca2+ concentrations reported for  = 0.5,
0.75, 1 are those following adjustment to new steady state;  = 0.2 was the initial value
used in all simulations in prior Sections.
[Ca2+]cyt is very stable to all levels of perturbation. Raising  increases [Ca2+]dts
somewhat. Despite the relatively modest changes in models’ resting states, peak [Ca2+]cyt
distributions resulting from a 5.5x IP3 stimulus applied to the new resting states are rightshifted as  increases for simulations ran with 1.2 mM Caex (Figure 3.9, left) but not
without Caex (Figure 3.9, right).
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Figure 3.9

Peak [Ca2+]cyt following IP3 stimulus for the state population satisfying
all resting and dynamic constraints following  perturbation.

A 5.5x IP3 stimulus was applied to the population of configurations stable in EDTA
following adjustment of  to the indicated values. Simulations were run with Caex set to
1.2 mM (left) or to 1 pM (right). The green and red dotted lines indicate average resting
and peak [Ca2+]cyt for  = 0.2.
These results imply the increase in peak [Ca2+]cyt in +Caex simulations as  is raised is
due to more STIM2 entering the puncta following store depletion and not due to higher
basal [Ca2+]dts or high  being able to decouple SOCE from [Ca2+]dts by strengthening the
influence of [Ca2+]cyt on the amount of STIM2 available to Orai (see Eqs. (2.4) and (2.5)).
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Figure 3.10

Increasing  leads to reduced system stability in Ca2+-free media.

Histograms of resting ISOC for the fully filtered state population following  perturbation
to the indicated values. The red dotted line indicates the value of ISOC above which the
stability criterion (see “Stable in EDTA” in Table 3.2) would be violated.
In Figure 3.10 we observe the effect of  on resting ISOC. Increasing the 
parameter in the puncta formation equation reduces the number of stable configurations
in the population initially satisfying all filtering conditions. A higher value of  increases
the number of active (STIM2)p at rest; resting ISOC increases correspondingly due to there
being more open channels. Configurations with higher resting ISOC lose calcium more
quickly following EDTA application. The ISOC cutoff is equivalent to the rate of change
of [Ca2+]dts criterion indicated in Table 3.2; this is because PM flux is the rate-limiting
step for Ca2+ leakage. As a more extreme example we could set the entire p parameter to
unity (i.e. making all STIM2 is available to Orai) which causes the entire population of
configurations that were previously viable according to our criteria to fail the stability in
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EDTA criterion (data not shown). Thus a higher  is able to cause more STIM dimers to
be present in the puncta under resting conditions, despite higher levels of store filling.

3.4 Discussion
This chapter has been devoted to solving the inverse problem discussed in the
introduction as applied to a mechanistic model of SOCE in human platelets. In the
context of this problem, the “fitting data” consisted of both homeostatic constraints
derived from experiment and intuition and experimental [Ca2+]cyt transients in human
platelet populations stimulated in calcified and calcium-free conditions [150]. Our
parameter scan results reveal how a model’s topology and fixed parameters naturally
enforce constraints on the steady state configurations that a model is able to exhibit. The
model is able to take on physiologically acceptable configurations with mean values that
differ by no more than a factor of two from experimentally measured values for protein
copy numbers (typically measured with light scattering mass spectroscopy) or calcium
concentrations. Low resting levels of IP3 are required for system robustness and for
appropriate dynamic response to physiologic agonists.
Multiple steady states (the 1,513 ICs meeting the filtering criteria, see Figure 3.2
and Table 3.2) are expected and were sought out because: (i) total protein measurements
(Table 3.1) do not define the distribution of the protein sub-species (e.g. SERCAE1,
SERCAE2, etc) within the individual modules (Figure 2.2) where the six measured protein
levels for IP3R, SERCA, STIM, Orai, CaM, and PMCA are actually distributed over 24
states/complexes (see Table 2.1) which are not known but must be consistent with the
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topology, kinetic parameters, homeostasis requirement, and filtering criteria; (ii) cellular
heterogeneity is expected around a population average measurement and variations for a
particular protein could easily be ± 100 %; and (iii) the filtering criteria defined in Table
3.2 are based upon ranges and upper and lower bounds, not strict values (e.g. steady state
[Ca2+]cyt = 75 nM). The IC exploration range was also fairly restricted for IP3R, SERCA,
Orai, STIM, CaM, and PMCA around their measured values (Figure 3.2). The filtering
criteria and model topology was more restrictive of allowed ICs for SERCA, STIM, and
PMCA, but less so for IP3R, Orai, and CaM suggesting less model sensitivity to the
values of IP3R, Orai, and CaM; these broader distributions are also partly a consequence
of the relatively narrow sampling ranges used in comparison to prior work [57].
Membrane electric potential is an important parameter for modeling channel
current as it affects the driving force for passage of charged particles across a membrane.
The potential across the inner membrane (VIM) is largely unexplored due to being
difficult to assess with traditional patch-clamp techniques [116]. VIM acts in opposition to
the favorable calcium concentration gradient across the IM, effectively acting as a brake
on calcium release and functionally placing a lower bound on [Ca2+]dts by setting the
Nernst potential at which calcium flux out of the DTS via IP3R is zero (see Eq. (2.2)). In
agreement with this idea, in our model resting configurations satisfying only the static
constraint of being stable in EDTA show a broad distribution of VIM values (see Figure
3.2), however following application of the two dynamic constraints, VIM clusters to the
high (less negative) end of the sampling range; a higher VIM is evidently required to
support the rate and amount of calcium release required for platelet activation.
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The requirement of a resting model configuration approximately remaining at
steady state on Caex removal necessitates a low resting flux through SOCs. This is
coupled with a requirement that following activation SOCE flux rises to levels that are
sufficient to elevate [Ca2+]cyt and effects store refilling. These points mean that a model
for SOCE needs to have significant cooperativity with respect to decreases in [Ca2+]dts.
Cooperativity is introduced in three steps. The first is STIM oligomerization following
loss of bound DTS Ca2+ which is well supported by experiments showing increases in
STIM-STIM FRET following store depletion [60, 153]. The second facet of cooperativity
comes from graded activation of Orai by association with multiple STIM dimers modeled
with Eq. (2.6) [85]. We model STIM-Cadts association and STIM dimerization with mass
action kinetics; this leads to nonzero STIM2 at rest even when stores are full. The third
cooperative mechanism, enforcing STIM2 needing to be in the puncta before being able
to associate with Orai, is necessary for the model to both have a low enough resting ISOC
flux to be stable in EDTA and to simultaneously exhibit appreciable SOCE contribution
to [Ca2+]cyt following stimulus (see Figure 3.10). We see a small time delay in peak
[Ca2+]cyt compared to simulations run without Caex (see Figure 3.3, Figure 3.4 B and
Figure 3.5) which could conceivably be due to this puncta mechanism because of its
dependence on [Ca2+]cyt. Fluorescently labeled human platelets stimulated with ADP
show [Ca2+]cyt peaking within 5 – 10 s of agonist addition and show little difference in
peak time in calcium-containing versus calcium-free conditions (see right panel in Figure
3.5) [150]. However some groups have observed in fluorescently labeled cells following
application of thrombin, which is a stronger platelet agonist, a fast rise in [Ca2+]cyt
followed by a slower increase [151]. In addition our own group routinely observes a time
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difference of about 20 s between agonist delivery and peak [Ca2+]cyt in fluorescently
labeled 10% PRP under calcium-free conditions [43].
This lag in SOCE deactivation may be due to missing regulation rather than a
deficiency with our method of handling puncta entry. Evidence for alternative regulation
of SOCE inactivation has been observed in the literature. Studies have reported that
CRACR2A, a transmembrane protein with a cytosol facing EF-hand domain, may be
responsible for stabilizing the STIM-Orai complex and that this effect is inhibited at high
[Ca2+]cyt [154]. STIM also may be able to interact with phosphoinositides in the PM via
its cytosolic polybasic domain. Inhibition of phosphotidylinositol 3-and 4-kinases has
been shown to reduce SOCE [155]. However, PIP and PIP2 levels do not change
appreciably in thrombin stimulated platelets [156]. Additionally, many Ca2+ channels,
including SOCs, are affected by the phenomena of Ca2+-dependent inactivation (CDI) in
which Ca2+ influx results in local domains of high [Ca2+]cyt which interferes with channel
operation [60]. This effect is independent of store refilling [157]. In the future, modeling
these regulatory mechanisms may allow for faster SOCE inactivation as stores refill.
Store refilling is often indirectly measured by observing changes in [Ca2+]cyt,
[Ca2+]dts or ISOC following Ca2+ addition in cell populations where stores have been
depleted with ionomycin and/or SERCA inhibitors such as thapsigargin [60, 157, 158];
these studies are not reflective of normal store refilling during agonist stimulation. Only a
few groups have directly measured [Ca2+]dts versus time in human platelets; this is
because most fluorescent calcium dyes are higher affinity dyes designed to measure
[Ca2+]cyt. One group has used Fluo-5N to measure [Ca2+]dts in human platelets following
stimulation with ADP and thrombin, among other compounds [146]. In the absence of
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Caex, no store refilling was observed following addition of these agonists; our model is
consistent with these measurements (see Figure 3.3). This same group observed fast
(within 30 s of agonist addition) but partial refilling when thrombin was added to
platelets in calcified media. Under strong IP3 stimulus with Caex, our model is capable of
0 to over 100% store refilling depending on the resting configuration. In Figure 3.7 A we
see the model does not show the amount of fractional refilling of stores being correlated
with peak [Ca2+]cyt time. However, Figure 3.7 B does show a correlation with the SERCA
/ IP3R ratio; taken together with the time courses shown in Figure 3.6, this implies that in
order to avoid a significant time delay in [Ca2+]cyt, the stores need to refill quickly only to
a level such that PMCA can overtake the SOCE flux rather than needing to refill
completely. CDI could be modeled to directly cause faster store refilling in early times
following activation as high [Ca2+]cyt in puncta microdomains also results in faster
SERCA activity in those regions; this scheme would create a scenario of fast store
refilling through active SERCA positively regulated by locally higher Ca2+ and CDI
dependent inactivation followed by a slower inactivation phase (perhaps dependent on
residual store refilling through less active SERCA mediated by bulk [Ca2+]cyt and
CRACR2A destabilization) which may be important for fully shutting off ISOC in model
configurations where stores only partially refill.
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Chapter 4
Conclusions and future directions
In this thesis, we have combined kinetic, mechanistic and electrochemical data to
produce a computational model of IP3-mediated calcium release and SOCE in human
platelets that can estimate the resting and dynamic behavior of platelets in both calciumcontaining and calcium-free conditions. The result is a systems-level model, integrating
measurements and observations from dozens of independent studies.
The model presented in this thesis is the first to our knowledge to incorporate a
complete mechanism for SOCE into a larger scale systems model of calcium signaling. In
Chapter 2 we outlined the model framework, using previous modeling work as a
foundation, which casts intracellular Ca2+ regulation as a function of the delicate balance
between the opposing actions of Ca2+ channels and pumps: IP3R, SERCA, SOCE, and
PMCA. The mechanism for SOCE employed mass action kinetics to model Ca2+ binding
and dimerization of the Ca2+ sensor STIM, a [Ca2+]cyt dependent Hill function to
determine STIM2 entry into the puncta, and a cooperative equilibrium model to govern
the association of STIM2 ligands with the channel-pore forming subunit, Orai.
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In Chapter 3 we studied how applying various homeostatic and dynamic
constraints affected the preferred resting configuration of the model. The model was able
to exhibit physiologic resting states with protein counts and fixed parameters (besides
those estimated in this study) close to cited literature values. The model predicted that
values of VIM, an experimentally inaccessible quantity, need to be greater than -70 mV in
order to achieve calcium release following agonist stimulation (Figure 3.2). The model
also possessed a subset of resting configurations that were able to recapitulate
experimentally measured [Ca2+]cyt time courses in human platelets under high ADP
stimulation (Figure 3.5). The ability of the model to maintain steady state in EDTA was
heavily dependent on enforcing physical separation of STIM2 and Orai at rest; increasing
the maximum fraction of STIM2 that is able to interact with Orai led to more resting
states failing our stability criterion due to raising constitutive leak through SOCs (Figure
3.10). Given the complexity of calcium regulation in biological systems, a cellular
signaling model will likely never be fully “complete.” In the future, incorporating
additional experimental data will allow for more tightly distributed protein copies and
will enable the inclusion of downstream platelet functionality such as granule secretion,
integrin activation, and phosphatidylserine exposure as well as the modeling of receptors
for other important platelet agonists such as thrombin and thromboxane.
There are two logical next steps one could take to further develop the model. The
first would be to incorporate calcium dependent inactivation of the STIM-Orai complex
as already discussed in Section 3.4. The second direction one could take is motivated by
the considerable homology in the activation pathways of the platelet agonists which
signal through GPCRs, namely: ADP (via the P2Y1 receptor), thrombin (via the PAR1
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and PAR4 receptors) and TxA2 (via the TP receptor). Following receptor binding, these
agonists stimulate Ca2+ release from stores via Gq (and Gi to a lesser extent) mediated
activation of PLC isoforms leading to phosphoinositide hydrolysis and IP3 generation
[5]. Upstream data on ADP mediated IP3 generation is already available from previous
modeling work [57]. Platelets experience these chemical cues simultaneously (among
others such as collagen which signals through GPVI and integrin 21). Most groups
still only measure the response of platelets to one agonist at a time; however, highthroughput “Pairwise Agonist Scanning” techniques have recently been developed to
yield high resolution Ca2+ fluorescence time course data on PRP stimulated with multiple
agonists simultaneously [43]. This technique has produced sufficient data to train neural
networks which have been used to model platelet activation in a multiscale lattice kinetic
Monte Carlo simulation of platelet aggregation under flow conditions [44] and these
works have already demonstrated the synergistic or non-additive effects applying
combinations these agonists have on platelets’ calcium responses.
One of the themes of the first chapter was how simple behaviors or mechanisms
can interact in nonlinear fashions to produce complex outputs or unexpected results. In
that vein, unexpected behaviors or interesting new predictions may result from modeling
PAR1, PAR4 and TP simply as three receptors of differing copy numbers and ligand
affinities, all sharing the same downstream signaling pathways.
Cell signaling networks are studied in a laboratory setting by delivering inputs to
cells (e.g. agonists) and then observing some measureable output, such as fluorescence
over time in cells labeled with a Ca2+ sensitive dye like fura-2. Accurate, mechanistic,
systems-level computational models of these networks serve as an invaluable partner to
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these wet-lab experiments by allowing one to probe the effects of altering the internal
workings of the system (i.e. a cell) on the output in a manner which may be technically
infeasible or impossible to do in a laboratory setting. In this way a systems model can
serve as a platform from which one can gain a greater understanding of biology and guide
future investigations of signaling pathways. With the amount of biological knowledge
becoming increasingly vast, computational models will likely take on an even more
important role going forward. Even with the advent of high-throughput experimental
techniques it is infeasible to explore the entire reaction network in cells (much less model
it). In light of this limitation, in the future systems models should serve both as a guide to
biologists as to which problems to solve and as a tool in interpreting complex
experimental results.
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APPENDIX
Appendix A.

Analytical solutions to the MWC equations

The system of equations given by Eq. (2.6) in Section 2.4.2 which govern the
association of (STIM2)p and Orai and set the distribution of SOC channel states do not
have a closed form solution in terms of Orai and (STIM2)p. The ten channel states were
solved for analytically in terms of Sf, the amount of STIM in the puncta which is not
bound to Orai, using the MATLAB Symbolic Toolbox. These solutions are listed below;
OraiT is the number of Orai tetramers in the system (and was one of the quantities that
were allowed to vary during parameter scan sweeps).

where ‘Denom’ is equal to

73

Appendix B.

Summary of algebraic IP3 forcing function
parameters

Max fold increase*
1.5
2
3
5
8
10
*Values are approximate.
Table A.1

a
0.03
0.1
0.3
0.7
1.35
1.75

b
0.06
0.06
0.08
0.08
0.08
0.08

c
0.15
0.2
0.38
0.4
0.4
0.4

tmax (s)
12.7
11.2
8.3
7.9
7.8
7.2

Exponential forcing function parameter sets.

Lists sets of parameters capable of eliciting various maximal fold increases in [IP3] using
the algebraic forcing function given by Eq. (2.8) in Section 2.5. The time gap between the
beginning of the IP3 stimulus and maximal [IP3] is indicated in the last column.
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